Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33 | -$29 | -$30 | -$22 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | $3 | $3 | $3 |
| Change in WC | $16 | $1 | -$2 | $3 |
| Other Non-Cash | -$0 | $0 | $0 | $0 |
| Operating Cash Flow | -$8 | -$24 | -$28 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$54 | -$49 | $0 | $0 |
| Inv. Sales/Matur. | $18 | $3 | $0 | $10 |
| Other Inv. Act. | -$15 | $0 | $0 | $0 |
| Investing Cash Flow | -$51 | -$46 | -$0 | $10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$105 | $91 | $12 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $115 | $12 | $2 |
| Financing Cash Flow | $1 | $115 | $12 | $2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$58 | $44 | -$17 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $102 | $58 | $75 | $78 |
| End Cash | $44 | $102 | $58 | $75 |
| Free Cash Flow | -$8 | -$24 | -$29 | -$15 |